Summary |
|
1 | (10) |
|
|
11 | (6) |
|
A Prior National Research Council Report on Controlled Human Exposure Studies |
|
|
11 | (1) |
|
|
12 | (2) |
|
EPA's Office of Inspector General Report |
|
|
14 | (1) |
|
Committee's Statement of Task |
|
|
15 | (1) |
|
Terms for Referring to Individuals Exposed in CHIE Studies |
|
|
15 | (1) |
|
Organization of the Report |
|
|
16 | (1) |
|
2 Foundational Aspects Of Human-Subjects Research |
|
|
17 | (16) |
|
|
17 | (1) |
|
Air Pollution Health Effects Science for Managing Air Quality |
|
|
18 | (2) |
|
|
20 | (5) |
|
|
25 | (8) |
|
3 Value Of Controlled Human Inhalation Exposure Studies |
|
|
33 | (19) |
|
|
33 | (1) |
|
A Framework for Evaluating CHIE Studies |
|
|
34 | (2) |
|
|
36 | (1) |
|
CHIE Studies in the Context of Toxicologic and Epidemiologic Studies, and the Larger Research Agenda |
|
|
37 | (1) |
|
Use of Biomarkers in CHIE Studies |
|
|
37 | (1) |
|
Comparing CHIE Study Exposures with Ambient Pollutant Exposures |
|
|
38 | (2) |
|
Considerations of CHIE Study Value for EPA Decision Making |
|
|
40 | (1) |
|
|
40 | (4) |
|
|
44 | (7) |
|
|
51 | (1) |
|
4 Assessment Of Controlled Human Inhalation Exposure Studies At Epa And Associated Adverse Events |
|
|
52 | (16) |
|
|
52 | (1) |
|
The Eight Studies Identified by EPA for Consideration by the Committee |
|
|
53 | (8) |
|
Evaluation of Evidence for Adverse Events Resulting from Participation in a CHIE Study |
|
|
61 | (2) |
|
|
63 | (3) |
|
Relationship of Short-Term CHIE Study Exposure to Chronic Disease Risks |
|
|
66 | (1) |
|
|
67 | (1) |
|
5 The Continued Conduct Of Controlled Human Inhalation Exposure Studies By Epa |
|
|
68 | (9) |
|
Scientific Contributions of Past CHIE Studies |
|
|
68 | (1) |
|
|
69 | (2) |
|
|
71 | (3) |
|
Potential Future Societal Benefits |
|
|
74 | (1) |
|
Additional External Scientific Input |
|
|
75 | (1) |
|
Conclusion and Recommendation |
|
|
76 | (1) |
|
6 Characterizing Risks To Subjects In Controlled Human Inhalation Exposure Studies |
|
|
77 | (10) |
|
Audiences for Risk Characterization Associated with CHIE Studies |
|
|
77 | (1) |
|
Exclusion Criteria for Screening Study Subjects |
|
|
78 | (1) |
|
Factors That Might Trigger an Adverse Outcome |
|
|
78 | (1) |
|
What Adverse Outcomes Might Be Expected and When? Reasonably Foreseeable Risks |
|
|
79 | (1) |
|
Characterization of Risks Associated with CHIE Pollutant Exposures |
|
|
79 | (1) |
|
Use of the Exposure Comparator Approach for Characterizing Risk |
|
|
80 | (5) |
|
|
85 | (2) |
|
7 Communication About Informed Consent In Controlled Human Inhalation Exposure Studies |
|
|
87 | (19) |
|
Introduction to Informed Consent and the Common Rule |
|
|
87 | (3) |
|
Researcher Communication and Participant Understanding of Informed Consent |
|
|
90 | (3) |
|
|
93 | (2) |
|
|
95 | (11) |
|
|
|
A Biographical Information On The Committee On Assessing Toxicologic Risks To Human Subjects Used In Controlled Exposure Studies Of Environmental Pollutants |
|
|
106 | (4) |
|
B Public Information-Gathering Sessions |
|
|
110 | (2) |
|
C Assessment Of Eight Controlled Human Exposure Studies |
|
|
112 | |